{"title": "ACUTE MEDICAL ILLNESS BODY FLUID AND ELECTROLYTE DISORDERS OBSTRUCTIVE LUNG DISEASES PROSTAGLANDINS CLINICAL ALLERGY GASTROINTESTINAL MOTILITY DISORDERS ANTIMICROBIAL THERAPY LIPID DISORDERS INTESTINAL INFECTIONS TREATMENT OF SKIN DISEASES CLINICAL PHARMACOLOGY OF SYMPTOM CONTROL DIABETES MELLITUS INFECTIONS IN OFFICE PRACTICE CLINICAL GERIATRIC MEDICINE RESPIRATORY FAILURE ACID-BASE DISORDERS MEDICAL VIROLOGY CRITICAL CARE MEDICINE", "body": "Arachidonic acid (Continued) in prostaglandin synthesis, 1981: July, 716--720 metabolites, as nlediators of hypersensitivity and inflammation, 1981: July, 809-828 . ARDS. See Respiratory distress syndrolne, adult. Arrhythmia(s). See also specific disorders.\n\ncardiac, chronic airflow obstruction : May, 554 in aged, 1983 : March, 387-390 ventricular, in acute respiratory failure, 1983 : May, 735 Arteritis, temporal, 1982 : July, 952 in aged, 1982 Arthritis, acute, 1981 : Jan., 177-188 digital, in psoriasis, 1982 : July, 773-774 in aged, 1982 : Sept., 1033 -1036 bronchial reactivity and, 1981 : May, 475 bronchoconstriction of, 1981 control of, 1981 : Sept., 1033 -1043 corticosteroids in, 1981 : Sept., 1059 drug therapy for, 1981 : May, 579-613 eosinophilia in, 1981 immunotherapy for, 1981 : Sept., 990-993 nlast cells in, 1981 -1018 nledications for, 1981 -1040 neurogenic mechanisms in, 1981 : Sept., 1023 occupational, 1981 : May, 697-700 pathogenesis and pathophysiology of, cellular mechanisms in, 1981 : Sept., 1013 -1031 pregnancy and, 1983 : May, 682 Astrovirus(es), 1982 : May, 587-588 Astrovirus infection(s), gastroenteric, 1983 Sept., 1047 Ataxia telangiectasia, 1981: Sept., 966 Atelectasis, radiographic features of, 1983 : Nov., 1321 Atherogenesis, arachidonic acid lnetabolisnl and, 1981 : July, 867-870 Atherogenic hyperlipoproteinenlia, 1982 March, 375-402 I~DEX Antimicrobial drug(s), comparative costs, 11)83: Jan., 174 in enteric infections, 1983: Jan., 214--216 oral, 1983: Jan., 57-98 . See also specific drug, as Penicillin. outpatient use, 1983: Jan., 3-16 prophylactic, 1983: Jan., 99-112 Antimicrobial therapy, administration : Jan., 9--10 choosing of appropriate agent, 1982 : Jan., 6--9 combination, 1982 : Jan., 17-24 liver disease and, 1982 : Jan., 257-266 monitoring, 1982 : Jan., 10--11 principles of, 1982 : Jan., 3-15 renal insufficiency and, 1982 : Jan., 267-281 resistance to, 1982 : Jan., 25-37 Antimonials, for parasitic infections, 1982 Jan., 249 Antimycotic agent(s), in dermatomycoses, 1982: July, 887-893 Antipseudomonas penicillins. See specific agent, such as Carbenicillin. Antip~ychotic drug(s), 1982: Sept., 993-1009 : March, 370--371 Antisera, viral, 1983 Antistaphylococcal penicillin(s), 1982: Jan., 51-60. See also Penicillins, antistaphy/ococcal. Antituberculous agent(s), 1983: Jan., 80--83 Antiviral drug(s). See Drug ( si, antidral or under specific agent, as Vidarabine. Antiviral therapy, 1982 : Jan., 235-244 Anxiety, in aged, 1982 : March, 368 in terminally ill, 1982 : Sept., 1016 , 1177 with acute illness, 1981 : Jan., 5 Aorta, aneurysms of, 1981 dissection, pain of, 11)81: Jan., ,59 Apnea, sleep, 1981: May, 558; : Sept., 980--982 in aged, 1983 : March, 424 with high-frequency ventilation, 1983 : May, 638 Apoplexy, pituitary, 1981 : Jan .. 105-116 Apoprotein B, overproduction, in hypertriglyceridemia, 1982 : 1-.Iarch, 523-525 Apoprotein E phenotypes, prevalence in population, 1982 : March, 445-447 Apoprotein E polymorphism, biochemical genetics, 1982 : }'larch, 442-446 Appendix, ulcerations, due to Yersinia infection, 1982 cardiac, chronic airflow obstruction and, 11)81. }, Iay, 554 in aged, 1983 : March, 387-390 ventricular, in acute respiratory failure, 1983 : May, 735 Arteritis, temporal, 1982 : July, 952 in aged, 1982 Arthritis, acute, 1981 : Jan., 177-188 digital, in psoriasis, 1982 : July, 773-774 in aged, 1982 : Sept., 1047 -1052 rheumatoid. See Rheumatoid arthritis. Articulation. See Joint. Ascariasis, drug therapy for, 1982 : May, 724--729 Aspergillosis, bronchopulmonary, allergic, 1981 , 1061 Aspergillus pneumonia, 1983 1244--1245 Aspirin. See Acetylsalicylic acid. : },Iay, 456 acute, 1983 : May, 669-684 airway hyperreactivity in, 1981: Sept., 1024--1026 assessment oC 1981: Sept., 1033 -1036 bronchial reactivity and, 1981 : May, 47.5 bronchoconstriction of, 1981 control of, 1981 : Sept., 1033 -1043 corticosteroids in, 1981 : Sept., 1059 drug therapy for, 1981 : },Iay, 579-613 eosinophilia in, 1981 immunotherapy for, 1981 : Sept., 990--993 mast cells in, 1981 --1018 medications for, 1981 -1040 neurogenic mechanisms in, 1981 : Sept., 1023 occupational, 1981 : May, 697-700 pathogenesis and pathophysiology of, cellular mechanisms in, 1981 : Sept., 1013 -1031 pregnancy and, 198.3: May, 682 Astrovirus(es), 1982 : May, .587-588 Astrovirus infection(s), gastroenleric, 1983 Sept\" 1047 Ataxia telangiectasia, 1981: Sept., 966 Atelectasis, radiographic features of, 1983 : Nov., 1321 Atherogenesis, arachidonic acid metabolism and, 1981 : July, 867-870 Atherogenic hyperlipoproteinemia, 1982 March, 375-402 Atherosclerosis, high density lipoproteins and, 1982 : March, 331, 390 in diabetics, 1982 : Nov., 1347 in dogs, I)-very low density lipoproteins and, 1982 : March, 393-395 in familial dysbetalipoproteinen1ia, 1982 : March, 450-451 in hyperlipidemia, 1982 : March, 331 LDL stimulation of cell growth and, 1982 March, 397 low density lipoproteins and, 1982 : March, 395-396 macrophage accumulation hypothesis, 1982 : March, 39~397 pathogenetic models, 1982 : March, 377 plasma triglycerides and, 1982 Athlete's foot, 1982: July, 878 Atopic disorders, immunotherapy of, 1981: Sept., 987-1012 adverse reactions to, 1981: Sept., 1002 selecting patients for, 1981: Sept., 998-1000 Autoimmune disorder(s). See also specific disorders, as Myasthenia gravis. : Nov., 1215 --1217 renal tubular acidosis and, 1983 : July, 872 Autosensitization, immunodeficiency and, 1981 : Sept., 960 Azlocillin, 1982 : Jan., 61-73 Azotemia, prerenal, 1981 : March, 414 BACAMPICILLIN, 1983 : Jan., 64-65 Bacillus Calmette-Guerin, prostaglandins and, 1981 : July, 836 Bacillus cereus, enterotoxigenic, 1982 : May, 605 Bacitracin, for antibiotic-associated pseudomembranous colitis, 1982 : May, 660--661 Bacteria, antibiotic-resistant, control of in hospitals, 1982 : Jan., 34-35 Bacterial infection(s), in aged, 1983 : March, 273-287 Bacterial intestinal infection, in immuno-compron1ised patient, 1982 : May, 747 Bacterial overgrowth syndromes, 1982 . See specific pathogens. Bacteriuria, asymptomatic, 1983 : Jan., 195 in aged, 1983 : March, 284-285, 452-453 Balantidiuln coli infection, treatment, 1982 May, 713 Balloon tamponade, for variceal : Nov., 1220 Barbiturates, overdose, management of, 1983 : Nov., 1288-1289 INDEX Barotraulna, puln10nary, in acute respiratory failure, 1983 : May, 694-695, 727-728 Bartter's syndrolne, 1981 : July, 895-898 prostaglandins and, 1981 . See Amlnonia; Bicarbonate. Basophils, in immediate hypersensitivity reactions, 1981 : Sept., 945-950 Bears disease, 1983 : Sept., 98~987 B-cell deficiency syndrolnes, 1982 : May, 744-746 Beclomethasone, 1981 : Sept., 1077 Behavioral therapy, in gastrointestinal diseases, 1981 : Nov., 1397 -1411 Benoxaprofen, for pain, 1982 Benzocaine, dermatitis from, 1981 : Sept., 1084 Benzodiazepine(s), in aged, 1982 -1035 : March, 374-375 Benzolan1ide, 1981 : March, 292 Benzoyl perOXide, dermatitis from, 1981 Sept., 1085 for acne, 1982: July, 857-858 Beta-adrenergic drug(s), effects, in : Nov., 1382 -1383 Beta 2 -agonists, 1981 in cor pul~onale, 1981: May, 514 Beta-Iactam antibiotic(s), resistance to, 1982:\n\nJan., 28-31 Betamethasone, for asthn1a, 1981 : May, 602 Bethanechol, for gastroesophageal reflux, 1981 : Nov., 1228 Bicarbonate, concentration, in respiratory failure, 1983 : May, 645-656 Pco 2 and, in regulation of pH, 1983 : July, 800 in respiratory alkalosis, 1983 : July, 917-922 renal reabsorption of, 1981 : July, 753-768, 84~847 in n1etabolic alkalosis, 1983 : July,905-906 in renal failure, 1983 in renal tubular acidosis, 1983: July, 860--862 nephron sites of, 1983 : July, 763-767 serum, in mixed acid-base disorders, 1981 : March, 352-355 Bicarbonate buffer system, 1983 : July, 773 Bicarbonate-chloride exchange mechanislns. 1983 : July, 762-763 Bicarbonate therapy, alkalosis and, 1983 : July, 910--911 in ketoacidosis, 1983 : Nov., 1194 : July, 825-827 Biguanides, lactic acidosis and, 1983 : July, 822-823 Bile-acid binding resins, for hypercholesterolemia, 1982 : March, 540-542 Atherosclerosis, high density Iipoproteins and, 1982 : March, 331, :390 in diabetics, 1982 : Nov., 1347 in dogs, j3-very low density Iipoproteins amI. 1982 in familial dyshetalipoproteinemia, 1982 : March, 450-451 in hyperlipidemia, 1982 : March, 331 LDL stimulation of cell growth and, 1982 March,397 low density Iipoproteins and, 1982 : March, 395-396 macrophage accumulation hypothesis, 1982 : March, 396-397 pathogenetic models, 1982 : March, 377 plasma triglycerides and, 1982 : March, 519-522 Athlete's foot, 1982 : July, 878 Atopic disorders, immunotherapy of, 1981 Sept., 987-1012 adverse reactions to, 1981: Sept., 1002 selecting patients for, 1981: Sept., 998-1000 Autoimmune disorder(s). See also specific disorders, as Myasthenia gravis. diahetes and, 1.982: Nov., 1215 -1217 renal tubular acidosis and, 1983 : July, 872 Autosensitization, immunodeficiency and, 1981 : Sept., 960 Azlocillin, 1982 : Jan., 61-73 Azotemia, prerenal, 1981 : ~larch, 414 BACAMPICILLIN, 1983 : Jan., 64--65 Bacillus Calmette-Guerin, prostaglandins and, 1981 : July, 836 Bacillus cereus, enterotoxigenic, 1982 Bacteriuria, asymptomatic, 1983 : Jan., 195 in aged, 1983 : March, 284--285, 452-453 Balantidium coli infection, treatment, 1982 : May, 713 Balloon tamponade, for variceal bleeding, 1983 : Nov., 1220 Barbiturates, overdose, management of, 1983 : Nov., 1288 Pco, and, in regulation of pH, 1983: July, 800 in respiratory alkalosis, 1983: July, 917-922 renal reabsorption of, 1981: March, 334; : July, 753-768, 846-847 in metabolic alkalosis, 1983 : July,905-906 in renal failure, 1983 : July, 849-850 in renal tubular acidosis, 1983 : July, 860-862 nephron sites of, 1983 : July, 763--767 serum, in mixed acid-base disorders, 1981 : March, 352-355 Bicarbonate buffer system, 1983 : July, 773 Bicarbonate-chloride exchange mechanisms, 1983 : July, 762-763 Bicarbonate therapy, alkalosis and, 1983 : July, 910-911 in ketoacidosis, 1983 : Nov., 1194 --119.5 in lactic acidosis, 1983 : July, 825-827 Biguanides, lactic acidosis and, 1983 : July, 822-823 Bile-acid binding resins, for hypercholesterolemia, 1982 : March, 540-542 Biliary tract, disorders, in aged, 1983 : March, 436 infections, cephalosporins for, 1982 See also under specific organ or procedure. of brain, in herpes sinlplex encephalitis, 1983 : Sept., 998--1001 Bithionol, for parasitic infections, 1982 : Jan., 250 Bladder, bacteriuria of, antinlicrobials for, 1982 : Jan., 206 neurogenic, in aged, 1983 : March, 457-458 Blastomycosis, South American, 1982 : Nlay, 680--683 Bleeding. See Hernorrhage . Blepharitis, 1983 trol, 1982 : Nov., 1255 --1260 control, during pregnancy, fetal nlalformations and, 1982 : Nov., 1333 -133.5 during surgery, 1982 : Nov., 1361 -1372 glycosylated henloglobin and, 1982 : Nov., 1309 -1315 measurements, in diagnosis of diabetes, 1982 -1200 meticulous control of, 1982 : Nov., 1317 -1324 during pregnancy, 1982 : Nov., 1329 -1333 self-monitoring of, 1982 : Nov., 1227 -1250 , 1259 -1260 in patient education, 1982 : Nov., 1302 -1303 target levels, in diabetics, 1982 : March, 256-259 Body \\veight, diabetes and, 1982 : Nov., 1196 Bone, buffering by, 1983 : July, 777-778 disease, in aged, 1983 : March, 356, 517-524 infections, cephalosporins for, 1982 : Jan., 186-188 loss, age-related, 1983 : March, 518 nutritional status and, 1983 : March, 301-303 skeletal, age-related changes, 1983 : March, 517-518 Bone resorption, prostaglandins and, 1981 : July, 846 Botulisnl, 1981 : Jan., 198 Bowel. See also Intestine(s). disorders, in aged, 1983 : March, 436 nl0tility, 1981 : Nov., 1377 -1396 inflanllnatory disease, in aged, 1983 March, 442-443 irritable, syndrome of, 1981: :'\\0\\'., 1386 -1:391 behavioral therapy, 1981 : Nov. , 1402 -1404 obstruction of, in aged, 1983 : March, 437-438 Bowen's disease, in aged, 1983 : March, 539 Brain, traulna to, 1981 : Jan., 20 tumors, 1981 : Jan., 21-25 viral infection of, 1983 : Sept., 991-100B reast, cancer of, RNA viruses and, 1983 : Sept., 1110 Ventilation. disordered, in aged, 1983 Ventilation. disordered, in aged, : rvlarch, 422-42.5 intennittent positive-pressure, 1983 Biliary tract, disorders, in aged, 1983 : March,436 infections, cephalosporins for, 1982 See also under specific organ or procedure. of brain, in herpes simplex encephalitis, 1983 : Sept., 998-1001 Bithionol, for parasitic infections, 1982 : Jan., 250 Bladder, bacteriuria of, antimicrobials for, 1982 : Jan., 206 neurogenic, in aged, 1983 : March, 457-458 Blastomycosis, South American, 1982 trol, 1982 : Nov., 1255 -1260 control, during pregnancy, fetal malformations and, 1982 : Nov., 1333 -133.5 during surgery, 1982 : Nov., 1361 -1372 glycosylated hemoglobin and, 1982 : Nov., 1309 -1315 measurements, in diagnosis of diabetes, 1982 -1200 meticulous control of, 1982 : Nov., 1317 -1324 during pregnancy, 1982 : Nov., 1329 -1333 self-monitoring of, 1982 : Nov., 1227 -1250 , 1259 -1260 in patient education, 1982 : Nov., 1302 -1303 target levels, in diabetics, 1982 : March, 256-259 Body weight, diabetes and, 1982 : Nov., 1196 Bone, buffering by, 1983 : July, 777-778 disease, in aged, 1983 : March, 356, 517-524 infections, cephalosporins for, 1982 : Jan., 186-188 loss, age-related, 1983 : March, 518 nutritional status and, 1983 : March, 301-303 skeletal, age-related changes, 1983 : March, 517-518 Bone resorption, prostaglandins and, 1981 : July, 846 Botulism, 1981 Bowe I. See also I ntestine ( s). disorders, ill aged, 1983 : March, 436 motility, 1981 : Nov., 1377 -1396 inflammatorv disease, in aged. 1983 March, 442-443 irritable, syndrome of, 1981: \\'m., 1386 -1:391 hehavioral therapy, 1981 : Nov., 1402 -1404 obstruction of, in aged, 1983 : March, 437-438 Bowcn's disease, in aged, 1983 : March, 539 Brain, trauma to, 1981 : Jan., 20 tumors, 1981 -1283 control of, during surgery, 1982 : Nov., 1361 -1372 with insulin, 1982 : Nov., 1251 -1267 diagnosis of, 1982 : Nov., 1197 -1205 gestational, 1982 : Nov., 1194 , 1326 -1329 glycosylated hellloglobin and, 1982 : Nov., 1309 -1315 hyperlipidemia with, 1982 : Nov., 1347 -1360 diet therapy for, 1982 : March, 503-504 hyperosnl0lar nonketotic, 1983 : Nov., 1198 : Nov., 1373 -1388 insulin requiring, nlultiple subcutaneous insulin injections in, 1982: Nov., 1251-1267 lactic acidosis and, 1983: July, 821 male sexual dysfunction in, 1982: Nov., 1389-1396 nlaturity onset of youth, 1982 : Nov., 1197 nleticulous control of, 1982 : Nov., 1317 -1324 during pregnancy, 1982 1329---1333 neuropathy : Jan., 195 patient education in, 1982 : Nov., 1293 -1307 pregnancy and, nlanagement of~1982: Nov., 1325 -1346 : July, 759-771 psychological aspects of, 1982 : Nov. , 1285 -1292 self-monitoring of blood glucose in, 1982 : Nov., 1227 -1250 symposium on, 1982 : Nov., 1191 -1396 Diabetic gastroparesis, 1981 : Nov., 1279 1983: July, 831-843; : Nov., 1193 -1198 Diabetic retinopathy, effect of punlp therapy on, 1982 : Nov., 1279 ---1280 Diagnostic virology, 1983 : Sept., 935-951 rapid. 19R3: Sept., 953-972 Diah'sis, hicarbonate-buffered, in lactic aci-'dosis, 1983 : July, 826-827 in acute tubular necrosis, 1981 : Jan., 160 peritoneal, in psoriasis, 1982 : May, 788 renal, pruritus in, 1982 : Sept., 1127 -1128 Diarrhea, 1981 Diabetes mellitus (Collfilllll'd) concomitant : NO\\'\" 1194 continuous insulin infusion in, 1982 : \\lov\" 1269 -1283 control of, during surgery, 1982 : Nov\" 1361 -1372 with insulin, 1982 : Nov\" 1251 -1267 diagnosis of, 1982 : Nov\" 1197 -1205 gestational, 1982 : Nov\" 1194 , 1326 --1329 glycosylated hemoglobin and, 1982 : Nov\" 1309 -1315 hyperlipidemia with, 1982 : No\\'\" 1347 -1360 diet therapy for, 1982 : l\\larch, 503-504 hyperosmolar nonketotic, 1983 : Nov\" 1198 : Nov\" 1373 -1388 insulin requiring, multiple subcutaneous insulin injections in, 1982: Nov\" 1251-1267 lactic acidosis and, 1983: July, 821 male sexual dysfunction in, 1982: NO\\ 1389-1396 maturity onset of youth, 1982 : Nov\" 1197 meticulous control of, 1982 : NO\\ 1317 -1324 during pregnancy, 1982 : \\lo\\', 1329 --1333 neuropathy of, 1981 : Jan\" 195 patient education in, 1982 : No\\'\" 1293 -1307 pregnancy and, management of, 1982 --1346 : July, 759-771 psychological aspects of, 1982 1285--1292 self-monitoring of blood glucose in, 1982:\n\nNov\" 1227-1250 symposium : Nov\" 1191 -1396 Diabetic gastroparesis, 1981 : Nov\" 1279 : July, 831-843: 1983 : May, 663 in aged, 1983 : March, 28~287 antidiarrheal, 1983 : Jan., 211-213 antihypertensive, in diabetics, 1982 : Nov., 1379 antinlicrobial, outpatient use, 1983 Jan., [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . See also specific drug, as Penicillin. side effects : Jan., 113-129 antiviral, 1982 : Sept., 1111 -1113 : Sept., 1163 -1172 in chlamydial infections, 1983 : May, 663 in aged, 1983 : March, 285-287 antidiarrheal, 1983 : Jan., 211-213 antihypertensive, in diabetics, 1982 : Nov., 1379 antimicrobial, outpatient use, 1983 Jan., 3--16,57-98 . See also specific drug, as Penicillin. side effects : Jan., 113--129 antiviral, 1982 : Sept., 1111 -1113 : Sept., 1163 --1172 in chlamydial inh,ctions, 1983 azo, urticaria and, 1982 : July, 83.5 Dysbetalipoproteinelllia, fanlilial, 1982 : March, 441-452 Dysentery, amoebic, treahnent, 1982 : May, 708-709 bacillary, 1982 : May, 623-638 in intestinal mnoebiasis, 1982 : May, 692-693 Dyskinesia, tardive, with neuroleptics, 1982 Dysnlenorrhea, prostaglandins and, 1981 : July, 930 Dysphagia, in aged, 1983 : March, 349, 433-434 oropharyngeal, 1981 : Nov., 11.59-1167 Dyspnea, in aged, 1983 in terminally ill of insulin, 1982 : Nov., 1322 toxic, 1981 : Jan., 23, 28-31 Endocarditis, infectious, in aged, 1983 : March, 282-284 prophylaxis, 1983 : Jan., 106--108 rifampin for, 1982 : Jan., 160 Endocrine disorders, autoiIllmune, diabetes and, 1982 : Nov., 1215 -1217 critical, 1983 : Nov., 1193 -1213 : March, 481-495 Endophthalmitis, bacterial, 1983 : Jan., 149 Endoscopy, in gastrointestinal bleeding, 1983 azo, urticaria and, 1982 : July, 8:35 Dysbetalipoproteinemia, familial, 1982 : March, 441-452 Dysentery, amoebic, treatment, 1982 : May, 708--709 bacillarv 1982 in intes'tlnal amocbi~sis, 1982: ~1ay, 692-69:3 Dyskinesia, tardive, with neuroleptics, 1982 Dysmenorrhea, prostaglandins and, 1981 : July, 9:30 Dysphagia, in aged, 1983 : March, :349, 4:33-4:34 oropharyngeal, 1981 : Nov., 1159 --1167 Dyspnea, in aged, 1983 in terminally ill, March, 282-284 prophylaxis, 1983: Jan., 106-108 rifampin for, 1982: Jan., 160 Endocrine disorders, autoimmune, : Nov., 1215 -1217 critical, 1983 : Nov., 1193 -1213 : ~Iarch, 481-495 Endophthalmitis, bacterial, 1983 : Jan., 149 Endoscopy, in gastrointestinal bleeding, 1983 -1268 gastrointestinal hornlones and, 1981 : Nov., 1112 -1115 : July, 774 radiographic evaluation, 1981 : Nov., 1173 -1194 Esophageal scintigraphy, 1981 : Nov., 1293 --1297 Esophageal spasn1, diffuse, 1981 : Nov., 1247 -1250 behavioral therapy for, 1981 : Nov. , 1401 : Nov., 1219 -1222 Esophagus, cancer of, in aged, 1983 : March, 440 disorders, chest pain fron1, 1981 : Jan., 61 in aged, 1983 : March, 433-434 Estriol, measurement of, in diabetic pregnancy, 1982 : Nov., 1337 -1341 Estrogen therapy, in acne, 1982 : July, 861-862 in osteoporosis, 1983 : Mar., 489-490 Ethacrynic acid, 1981 : March, 293 EthaIllbutol, 1982 : Jan., 82-83 Ethanol, lactic acidosis and, 1983 : July, 759-771 hyperkalemia and, 1981 .'~1arch, 37,5 serun1, hypertonic syndron1es and, 1981 : March, 281-284 tolerance, 1981 : July, 76,5 Glucose-6-phosphate dehydrogenase deficiency, lactic acidosis and, 1983 .' July, 824 Glucose tolerance test, oral, 1982 : Nov., 1200 -1204 Glycoslyated heI11oglobin, in diabetes I11ellitus, 1982 : Nov., 1309 -1315 levels, effect of pun1p therapy on, 1982 .' Nov., 1278 in diagnosis of diabetes, 1982 : Nov., 1204 Goecken11an's regin1en, in psoriasis, 1982 .' July, 782 Goiter, nodular, in aged, 1983 .' Nlarch, 508-0510 Gonad(s), disorders, in aged, 1983 : March, 488-492 Gonorrhea, 1982 : Jan., 240-242, 248 Gout, 1981 : March, 404 acute, 1981 : Jan., 179 Granulocytopenia, as drug reaction, 1981 Granulon1a inguinale, 1982 : July, 921-922 Granulon1a, trichophytic, 1982 .' July, 880--881 GranuloI11atosis, allergic, 1982 : July, 949-951 Wegener's, 1982 : July, 948-949 Granulomatous disease, chronic, 1981 : Sept., 968 Gray syndron1e, due to chloran1phenicol, 1982 .' Jan., 97-98 Griseofulvin, 1983 : Jan., 78-79 in fungal infections, 1982 : July, 888-889 Guillain-Barre syndron1e, 1981 HDL. See High density lipoproteins (HDL) . Health, models, in patient education, 1982: Nov., 1293-1307 Heart. See also Cardiac. arrhythmias. See Arrhytll1nia(s , 198.3.' March, 42.5 in aged, 198.3: .'vlarch, 433-444 in rcspiratory alkalosis, 198.3: July, 919 infections, 1983 : Jan., 20:3-220 inflammatory disease of. See I nfiu1Il1llatory bowel disease. motility disorders of (symposium), 1981 : Nov., 1109 -1141 behavioral approaches to, 1981 : Nov., 1397 -1411 neural regnlation of motility, 1981 : Nov., 1129 -1147 sleep physiology and, 1981 . Nov., 1:359-1376 '110\\., 1227 -1228 Genetic aspects, of diabetes, 1982 : Nov., 1210 -1212 , 1220 -1222 Genital herpes infections, in men, 198.3: Jan., 243-244 in women, 198.3: Jan., 226--228 Genital infection(s), viral, 198.3: Scpt., 1059 -1073 in homosexual men, 198.3: Sept., 1097 Genital ulcers, 1983 : Scpt., 1064 -106.5 Genitourinary tract, disorders, in aged, 198.3: March, 445--461 Geriatric medicine, clinical (symposium), 198.3: March, 263-543 Gestational diabetes, 1982 : Nov., 1194 -119.5, 1326 --1329 Giardiasis, in immunocompromised patient, 1982 : Mav, 749 metronidazole for, 1982 : Jan., 124 treatment, 1982 Gilles de la Tourette's syndrome, neuroleptics tor, 1.982: Sept., 100.5 Gland(s). See under specific type, as\n\nPituitary. Glomerular fimction, acute tubular necrosis and, 1981: Jan., 1.52 indices of, 198.3: :\\Iov., 1326 Glomerulonephritis, acute, 1981 : March, 416 in aged, 198.3: March, 470-472 renal failure and, 198.3: Nov., 1.327-1328 Glucagon secretjon, in diabetes mellitus, 1982 : NO\\., 1317 -1319 . See also Corticosteroid(s). deficiency of, hypomineralocorticoidism and, 198.3: July, 882 excess of, 198 's regimen, in psoriasis, 1982 : July, 782 Goiter, nodular, in aged, 1983 : March, 508-510 Gonad(s), disorders, in aged, 1983 : March, 488-492 Gonorrhea, 1982 : Jan., 240-242, 248 Gout, 1.981: ~larch, 404 acute, 1981 : Jan., 179 Granulocytopenia, as drug reaction, 198I: Sept., 1098 Granuloma inguinale, 1982 : July, 921-922 Granuloma, triehophytic, 1.982: July, 880-881 Granulomatosis, allergic, 1.982: July, 949-951 Wegener's, 1982 : July, 948-949 Granulomatous disease, chronic, 1981 : Sept., 968 Gray syndrome, due to chloramphenicol, 1982 : }an., 97-98 Griseofulvin, 1983 in Helnatologic reactions, to drugs, 1981 : Jan., 121-123 Hemodynmnic Inonitoring, of critically ill, 1983 : Nov., 1343 -1360 : Jan., 69-73 Helnoglobin Ale' See Glycosylated hemoglobin. Hemolytic anemia, drug-induced, 1981 Hemoperfusion, in drug eliInination, 1983 H emophilus influenzae pneunl0nia, 1983 Hemorrhage, diverticular, in aged, 1983 March, 441-442 evaluation and managenlent : Jan., 133-146 gastrointestinal, 1983 : Nov., 1215 -1231 in acute respiratory failure, 1983 : May, 729-733 liver disease and, 1981 : Jan., 218 lower gastrointestinal, 1983 : Nov., 1225 -1228 thrombolytic therapy and, 1983 : Nov., 1186 -1187 Hemostasis, 1981 : Jan., 133 Henderson-Hasselbalch equation, 1983 : May, 647, 653 in metabolic alkalosis, 1983 : July, 809 pH and, 1983 : July, 799 Henle's loop, bicarbonate reabsorption and, 1983 : July, 755 Heparin, low-dose, in prevention of thromboemboli, 1983 : Nov., 1180 -1181 Hepatic. See also Liver. Hepatic disorders, in aged, 1983 : March, 436 Hepatic encephalopathy, 1981 : Jan., 209-226 Hepatic reactions to drugs, 1981 INDEX Hepatitis, in hOll1osexual 111en, 1983 interferon fOl, 1983 : Sept., 1155 Hepatitis B vaccine, 1983 : Sept., 1132 -1137 Hepatitis B virus, oncogenicity of, 1983 : Sept., 1119 -1121 Heroin, for pain, 1982 Herpes genitalis, in men, 1983 : Jan., 243-244 in women, 1983 : Jan., 226-228 Herpes sinlplex virus, detection of in cell culture, 1983 : Sept., 948-949 oncogenicity of, 1983 : Sept., 1112 -1115 Herpes sinlplex virus encephalitis, 1982 Sept., 991-1008 Herpes sinlplex infection : July, 807-810 drugs for, 1983 : Sept., 1164 -1167 genital, 1983 : Sept., 1059 -1064 in honlosexual nlen, 1983 in ilnmunocompronlised host, 1983 : Sept., 1082 : Sept., 974-982 Herpes simplex virus vaccine, 1983 : Sept., 1141 -1143 Herpes zoster ophthahnicus, 1983 : Sept., 982-985 Herpes zoster virus infection(s), 1982 : July, 810-812 in aged, 1983 : March, 288, 533-534 in immunocompronlised host, 1983 -1084 prevention, 1982 : Sept., 1109 -1110 : Sept., 1105 -1118 Herpetic esophagitis, in inlmunoconlpronlised patient, 1982 : May, 748 Hetacillin, 1983 : Jan., 63 Hiccough, in terminally ill, 1982 : Sept., 117.S High density lipoproteins (HDL), atherosclerosis and, 1982 : March, 331, 390 characterization, 1982 :~1arch, 403-404 clinical significance, 1982 : :Nlarch, 431-440 deficiency, with planar xanthonlatosis, 1982 : March, 479 diet-induced changes in, 1982 : March, 380-384 levels, effect of alcohol, 1982 Hemolytic anemia, drug-induced, 1981 Hemoperfusion, in drng elimination, 1983 Hemophilus injiuenzae pneumonia, 1983 Hemorrhage, diverticular, in aged, 1983 March, 441-442 evaluation and management : Jan., 133-146 gastrointestinal, 1983 : Nov., 1215 -1231 in acute respiratory failure, 1983: May, 729--733 liver : Jan., 218 lower gastrointestinal, 1983 : Nov., 1225 -1228 thrombolytic therapy and, 1983 : Nov., 1186 --1187 Hemostasis, 1981 : Jan., 133 Henderson-Hasselbalch equation, 1983 : May, 647, 653 in metabolic alkalosis, 1983 : July, 809 pH and, 1983 : July, 799 Henle's loop, bicarbonate reabsorption and, 1983 : July, 755 Heparin, low-dose, in prevention of thromboemboli, 1983 : Nov., 1180 -1181 Hepatic. See also Uver. Hepatic disorders, in aged, 1983 : March, 436 Hepatic encephalopathy, 1981 : Jan., 209-226 Hepatic reactions to drugs, 1981 I\"IDEX Hepatitis, in homosexual men, 1983 interferon fo!, 1983 : Sept., 1155 Hepatitis B vaccine, 1983 : Sept., 1132 -1137 Hepatitis B virus, oncogenicity of, 1983 : Sept., 1119 --1121 Heroin, for pain, 1982 Herpes genitalis, in men, 1983 : Jan., 243-244 in women, 1983 Herpes simplex virus, detection of in cell culture, 1983: Sept., 948-949 oncogenicity of, : Sept., 1112 Herpes simplex virus encephalitis, 1982:\n\nSept., 991-1008 Herpes simplex infection(s), 1982: July, 807-810 drugs : Sept., 1164 -1167 genital, 1983 : Sept., 1059 --1064 in homosexual men, 1983 in immunocompromised host, 1983 : Sept., 1082 : Sept., 974-982 Herpes simplex virus vaccine, 1983 : Sept., 1141 -1143 Herpes zoster ophthalmicus, 1983 982-985 Herpes zoster virus infection(s), 1982: July, 810-812 in aged, 1983 : March, 288, 533-534 in immunocompromised host, 1983 -1084 prevention, 1982 : Sept., 1109 --1110 : Sept., 1105 -1118 Herpetic esophagitis, in immunocompromised patient, 1982 : May, 748 Hetacillin, 1983 : Jan., 63 Hiccough, in terminally ill, 1982 19R2:~larch, 417-418 n1easuren1ent, 1982 :~1arch, 434-436 in clinical practice, 1982 :~1arch, 437-438 regulation, 1982 :~1arch, 403-430 Inetabolisn1, 1982 : March, 404-406 relation to very low density lipoproteins, 1982 : March, 521-522 subclasses, 1982 : March, 378-380, 433--434 with apo-E (HDLJ, origin, 1982 : March, 384-387 role in cholesterol n1etabolisn1, 1982 : March, 387-390 High-frequency ventilation, 1983 : May, 633-643 Hirschsprung's disease, 1981 : Nov. , 1380 -1382 Histalnine, in in1n1ediate hypersensitivity reactions, 1981 : Sept., 951 Histan1ine releasing agents, urticaria and, 1982 : July, 834 Histoplasmosis, 1982 Hives. See Urticaria. HLA antigens, diabetes and, 1982 -1196 , 1210 -1212 diabetic complications and, 1982 : Nov., 1217 -1218 : July, 833 RNA viruses and, 1983 : Sept., 1111 Homeostasis, n1echanisms of, 1981 : March, 284-286 Homosexual n1en, venereal disease in, 1983 -1104 Honeylnoon state, of insulin therapy, 1982 : Nov., 1239 Hookworm infection, 1982 : May, 731-742 Hordeolun1, 1983 : Jan., 222 Hydroxyurea, in psoriasis, 1982 : July, 787 Hymenolipiasis, 1982 : May, 739 Hymenoptera venon1, in ilnmunotherapy, 1981 : Sept., 996, 1002 Hyperaldosteronism, 1983 : July, 890-898 alkalosis and, 1983 : July, 912 secondary, 1983 : July, 895-898 Hyperalin1entation, parenteral, lactic acidosis and, 1983 : July, 823 Hyperbicarbonatelnia, 1981 : March, 333 Hypercalcemia, 1981 : March, 386-389 of cancer, prostaglandins and, 1981 : July, 845-853 Hypercalcemic crisis, 1983 : Nov., 1206 -1209 Hypercalciuria, renal tubular acidosis and, 1983 : July, 872-873 Hypercapnia, 1983 . See also Acidosis, respiratory. alkalosis and, 1983 : July, 911-912 chronic, 1983 417-418 measurement, 1982 : ~Iarch, 434-436 in clinical practice, 1982 : March, 437-438 regulation, 1982 : .March, 403-430 metabolism, 1982 : ~1arch, 404-406 relation to very low density lipoproteins, 1982 : March, ,521-522 subclasses, 1982 : March, 378-380, 433--434 with apo-E (HDLJ, origin, 1982 : March, 384-387 role in cholesterol metabolism, 1982 : March, 387-390 High-frequency ventilation, 1983 : May, 633-643 Hirschsprung's disease, 1981 : Nov., 138(}-l382 Histamine, in immediate hypersensitivity reactions, 1981 : Sept., 9,51 Histamine releasing agents, urticaria and, 1982 : July, 834 Histoplasmosis, 1982 Hives. See Urticaria. HLA antigens, diabetes and, 1982 -1196 , 1210 -1212 diabetic complications and, 1982 : .\\10\\ 1217 -1218 : July, 833 RNA viruses and, 1983 : Sept., 1111 Homeostasis, mechanisms of, 1981 : March, 284-286 Homosexual men, venereal disease in, 1983 -1104 Honeymoon state, of insulin therapy, 1982 : Nov., 1239 Hookworm infection, 1982 : May, 731-742 Hordeolum, 1983 : Jan., 13,5 Hormonal therapy, for central diabetes insipidus, 1981 . Sce also specific hormones.\n\nadrenocortical. See C orticosteroid( s). age-related changes, 1983 : ~arch, 481-495 gastrointestinal, migrating motor complex and, 1981 : Nov., 1318 -1319 : Nov., 1111 -1127 Host, de/ense, in cancer, prostaglandins and, 1981 : July, 829-844 f'lCtors, in obstructive pulmonary diseases, 1981 : May, 455--456 Human papilloma virus infection(s), 1982 : July, IH2-814 Humidification, in high-frequency ventilation, 1983 : ~1ay, 637 in mechanical ventilation, 1983 : May, 601-613 IIlllnoral immunity, assessment of, 1981 Sept., 974 Humoral mediator(s), of septic lung injury, 1983 : Mav, 703--708 Huntington's disease, in aged, 1983 : March, 356 neuroleptics for, 1982 Hydrochloric acid, in metabolic alkalosis, 1983 : May, 653--654 Hydrochlorothiazide, 1981 : March, 294, 317 Hydrogen ion, secretion, aldosterone and, 1983 : July, 880-881 in urinary acidification, 1983 : July, 753--768 Hydromorphone, for pain, 1982 11-I3-Hydroxyhse deficiency, 1983 : July. 893 17-a-Hydroxylase deficiency, 1983 Hydroxystilbamidine isethionate, f()f : Jan., 222 Hydroxyurea, in psoriasis, 1982 : July, 787 Hymenolipiasis, 1982 : May, 739 Hymenoptera venom, in immunotherapy, 1981 : Sept., 996, 1002 Hyperaldosteronism, 1983 : July, 890-898 alkalosis and, 1983 : July, 912 secondary, 1983 : July, 895-898 Hyperalimentation, parenteral, lactic acidosis and, 1983 : July, 823 Hyperbicarbonalemia, 1981 : March, 333 Hypercalcemia, 1981 : March, 386-:389 of cancer, prostaglandins and, 1981 : July, 84!Hl53 Hypercaicemic crisis, 1983 : Nov., 1206 -1209 Hypercaiciuria, renal tubular acidosis and, 1983 . July, 872-873 Hypercapnia, 1983 . See also Acidosis, respiratory. alkalosis and, 1983 : July, 911-912 chronic, 198.3: May, 648-649 H ypercholesterolemia, abnormalities of cholesterol transport in, 1982 : March, 371 differential diagnosis, 1982 : March, 539--540 familial, cholesterol synthetic rates, 1982 : March, 354-355 diet therapy for, 1982 : Match, 540 drug therapy for, 1982 : March, .540-.546 homozygous, 1982 Hypercholesterolelnia, f~1l11ilial, honlozygotes \\vith (Continued) nlechanisn1s for high plasnla LDL levels, 1982 :~larch, 346-3.51 therapy, 1982 : March, 3.58, .546 low density lipoprotein receptor defect in, 1982 :~larch, 335-362 pathogenesis at cellular level, 1982 : March, 338-341 pathogenesis at whole body level, 1982 : March, 341-343 surgery for, 1982 : March, .546 treatn1ent, 1982 : March, 3.55-3.58, 537-550 in diabetics, 1982 Hypercortisolisnl. See Cushing's disease. Hypereosinophilic syndronle, 1981 Hyperglycenlia. See also Diabetes lnellitus. consequences of, 1982 : Nov., 1319 hypertonic syndroInes and, 1981 :~larch, 281-284 Hyperkalenlia, 1981 July, 803 eIl1ergency treatnlent : Jan., 165-176 hyperchloren1ic Inetabolic acidosis and, 1983 : July, 789--790 hypoaldosteronisnl and, 1983 : July, 881-890 in hypertensive diabetics, 1982 : Nov., 137H in renal failure, 1983 : Nov., 1337 -1338 in renal tubular acidosis, 1983 : July, 874-876 in renal tubular necrosis, 1981 :~larch, 424 Hyperkeratosis, subungual, in psoriasis, 1982 : July, 773 Hyperlactacidenlia, 1983 : July, 815-829 Hyperlipiden1ia(s), approach to patient, 1982 : March, 319-333 athersclerosis in, 1982 : March, 331 diet therapy for, 1982 : March, 485-518 faIl1ilial dysbetalipoproteinen1ia and, 1982 : March, 448-4.50 hypertension with, salt restriction for, 1982 : March, .51:1-.51.5 in children, diet therapy for, 1982 : March, .504 of pregnancy, diet therapy for, 1982 : March, .504-.50.5 single diet concept for, 1982 :~1arch, 499--502 therapeutic decision-lnaking, 1982 : larch, 331-332 with diabetes, 1982 : Nov., 1347 -1360 diet therapy for, 1982 : March, .503-.50.f xanthon1as in, 1982 : March, 330-331 Hyperlipoproteinenlia, atherogenic, 1982 : March, 375-402 with diabetes, 1982 -13.51 INDEX Hypennineralcorticoidisn1, in Inetabolic alkalosis, 1983 : July, 907-908 H ypernatrelnia, hypertonic syndn)Jnes and, 1981 :~larch, 271-281 Hyperosnl0lality, 1981 :~larch, 272 in ketoacidosis, 1983 : July, 837 Hyperosnlolar nonketotic con1a, 1983 : Nov., 1198 Hyperparathyroidisn1, 1981 : March, 387 Hyperphosphaten1ia, 1981 : March, 391, 396-398 in chronic renal failure, 1981 : March, 442 Hyperplasia, nodular lynlphoid, 1982 .5 Hypersensitivity, arachidonic acid nletabolites as nlediators : July, 809-828 inlmediate, iInnlune n1echanisnls in, 1,981: Sept., 941-957 nlediators of, 1981 : Sept., 9.51-9.5.5 Hypersensitivity reactions, to penicillin, . 1983 : Jan., 114-121 Hypertension, hyperlipidelnia with, salt restriction for, 1982 : March, .513-.51.5 in aged, 1983 : March, 395-417 in diabetics, 1982 : Nov., 1373 -1388 : July, 906 puhnonary artery, in obstructive lung disease, 1981 : May, 489--49.5, .5.54 systolic, in diabet'ics, 1982 : Nov., 1378 -1379 Hyperthernlia, in overdose patient, 1983 -1283 Hyperthyroid crisis, 1983 : Nov., 1202 -1203 Hyperthyroidisnl, in aged, 1983 : March, 499--.503 nlyopathy of, 1981 : Jan., 197 Hypertonicity, hypernatren1ia and, 1981 : larch, 271-281 . potassiunl balance and, 1981 :~larch, 36.5 treahnent of, 1981 : lvlarch, 286-288 Hypertriglyceridelnia, 1982 : lvlarch, 519-535 in diabetics, 1982 -13.51 Inechanisn1s, 1982 : lvlarch, .522-.527 Hyperuricenlia, 1981 : March, 299, 403-409 Hypoadrenocorticisn1, 1983 : Nov., 1205 -1206 Hypoaldosteronisnl, 1981 : July, 881-890 H ypoalphalipoproteinelnia, fan1ilial, 1982 : March, 478 Hypobetalipoproteinenlia, f::lInilial, 1982 : March, 472-473 with chyloInicronelnia, 1982 : March, 474 Hypocalcelnia, 1981 : March, 389-392 Hypocalcen1ic crisis, 1983 : Nov., 1209 --1210 lI~vocapnia, 1983 levels, 1982 levels, . March, :346-3.51 therapy, 1982 levels, : 'vlarch, :358, 546 low density lipoprotein receptor defect in, 1982 levels, : 1\\1 arch, 335-362 pathogenesis at cellular level, 1982 March, 338--341 pathogenesis at whole body level, 1.982:\n\n~Iarch, 341-343 surgery hJr, 1982 : \"'larch, 546 treatment, 1982 : March, :35.5--358, 537-550 in diabetics, 1982 --1351 Hypercortisolism. See Cushing's disease. Hypereosinophilic syndrome, 1981 1066 Hyperglycemia, See also Diabetes lIlellitus.\n\nconsequences of~ 1982: Nov., 1:319--1320 hypertonic syndromes and, 1981 : l\\larch, 281-284 Hyperkalemia, 1981 July, 803 emergency treatment : Jan., 165-176 hyperchloremic metabolic acidosis and, 1983 : July, 789--790 hypoaldosteronism and, 1983 : July, 881-890 in hypertensive diabetics, 1982 : ]\\io\\,., 1371 in renal failure, 1983: ]\\io\\,., 1337 -1338 in renal tubular acidosis, 1983 : July, 874-876 in renal tubular necrosis, 1981 : March, 42.J Hyperkeratosis, suhungual, in psoriasis, 1982 : July, 773 lIyperiactacidemia, 1983 : July, 815-829 Hvperlipidemia(s), approach to patient, 1982 : March, 319-333 athersclerosis in, 1982 : 'vlarch, 331 diet therapy lor, 1982 : March, 485-518 Elmilial dysbetalipoproteinemia and, 1982 March, 448--450 hypertension with, salt restriction 1 (\", : March, 51:1-515 in children, diet therapy for, 1982 March, 504 of pregnanc)\" diet therapy for, 1982:\n\nMarch, .504-.505 single diet concept : l\\larch, 499--502 therapeutic decision-making, 1982 : March, 331-332 with diabetes, 1982 : Nov., 1347 -1360 diet therapy lor, 1982 : March, .S03-50.J xanthomas in, 1982 : l\\larch, 330-3.31 Hyperlipoproteinemia, atherogenic, 1982 March : \"larch, 513-515 in aged, 1983 : March, 395-417 in diabetics, 1982 : Nov., 1373 -1388 .July, 906 pulmonarv artery, in obstructive lung . Mav, 489--49.5, 554 systolic, in diabetics, 1982 : No\\'., 1378 -1379 Hyperthermia, in overdose patient, 1.983: Nov., 1282 -1283 Hyperthyroid crisis, 1983 . Nov., 1202 -1203 Hyperthyroidism, in aged, 1.983: March, 499--503 myopathy of, 1981 : Jan., 197 Hypertonicity, hypernatremia and, 1.981: March, 271-281 potassium balance and, 1981 : ~Iarch, .'365 treatment of 1981 : March, 286-288 Hypertriglyceridemia, 1982 : March, 519-535 in diabetics, 1982 --13.51 mechanisms, 1982 : l\\larch, .522-527 Hyperuricemia, 1.981: March, 299, 403-409 H ypoadrenocorticism, 1983 : No\\,., 120.5--1206 Hypoaldosteronism, 1981 . July, 881-890 lIypoalphalipoproteinemia, lamilial, 1982 March Hypochlorhydria, bacterial overgro\\vth and, 1982 :~1ay, .563 Hypocortisolisnl, 1983 : Nov., 120.t':r-1206 Hypoganlnlaglobulinenlia, COnl1110n variable acquired, 1982 :~Iay, 74.5 X-linked infantile congenital, 1982 : May, 74.5 Hypoglycenlia, exercise-induced, 1982 : Nov., 1246 : March, 486--487 prevention of, 1982 : Nov., 1261 -1262 \\vith continuous delivery of insulin, 1982: Nov., 1280--1281 Hypoglycelnic agents. See Insulin. Hypoglycemic coma, 1983 -1202 Hypokalenlia, 1981 : July, 803 hyperaldosteronisnl and, 1983 : N1ay, 73.5 orthostatic, \"in aged, 1983 : NIarch, 386-387, 404 in diabetics, 1982 : Nov., 1379 with tricyclic antidepressants, 1982 -1042 Hypothernlia, in aged, 1983 : NIarch, 336 Hypothyroid crisis, 1983 : Nov., 1203 -120.5 Hypothyroidisnl, hyponatrelnia \\vith, 1981 : NI arch, 267 in aged, 1983 :~larch, .503-.508 Hypotonic hyponatrelnia, 1981 : Nlarch, 267 Hypouricenlia, 1981 : March, 409 Hypoventilation, alveolar, 1983 : Jan., 189 in aged, 1983 : March, 427-429 prophylaxis, 1983 : Jan., 103-106 infiltrates with eosinophilia, 1981 : Sept., 1059 -1069 injury, in ARDS, 1983 : May, 689-690 prostaglandin metabolism in, 1981 : July, 789-808 secretions, in smokers, 1981 March, 264 in airways of smokers, 1981 : May, 673 Lymphogranuloma venereUln, 1982 : Sept., 106S--1067 Lymphoma, cutaneous T cell, : July, 895-913 viruses and, 1983 : Sept., 1110 , 1115 -1117 Lymphoproliferative disorders, 1981 : Sept., 970 McARDLE's syndrome, 1981 : Jan., 205 Macrodantin. See Nitrofurantoin. Macrophage, pulmonary, in sn10kers, 1981 : May, 668, 679 Magnesium, deficiency, in Bartter's syndrome, 1983 : July, 896 Magnesium balance, in chronic renal failure, 1981 : March, 437 Majocchi's granuloma, 1982 : July, 880-881 Malaria, prophylaxis, 1983 Malignant disease. See also Carcinoma. hematologic, disorders of phagocytosis with, 1981: Sept., 968 immunodeficiency and, 1981: Sept., 960 Malnutrition, imn1unodeficiency and, 1981: Sept., 970 protein-calorie, in acute respiratory failure, 1983 : May, 739 with hypolipidemia, 1982 : March, 479-480 Mannitol, 1981 Mast cell(s), in asthma, 1981: Sept., 1015-1018 in immediate hypersensitivity reactions, 1981: Sept., 94S--950\n\nNutritional status, asseSSlnent of: in critically ill, 1983 : Nov., 1297 , 1338 infection and, 1983 : Nov., 1297 Inaintenance of, in acute respiratory hlilure, 1983 : Mav, 739-741 respiratory Inus~le fatigue and, 1983 lay, 581-582\n\nNutritional support, excessive, in critically ill, 1983 : Nov., 1301 -1302 1110nitoring of, in critically ill, 1983 : Nov., 1300 -1302 OBESITY, diabetes and, 1982 "}